Nur Nicholson insider trades

Open-market stock purchases and sales by Nur Nicholson, Chief Technology Officer at Kailera Therapeutics, Inc, from SEC Form 4 filings since Jan 28, 2021.

Recent trades

DateStockTradeValue
Sep 7, 2026KLRA Kailera Therapeutics, IncBought (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncBought (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncBought (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncBought (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncBought (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)—
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)$1.6M
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)$3.4M
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)$1.8M
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)$2M
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)$1.9M
May 14, 2026APLS Apellis Pharmaceuticals, IncSold (not open market)$1.9M
Jan 28, 2026APLS Apellis Pharmaceuticals, IncBought (not open market)—
Jan 22, 2026APLS Apellis Pharmaceuticals, IncSold$168K
Jan 20, 2026APLS Apellis Pharmaceuticals, IncSold$43.6K
Jan 13, 2026APLS Apellis Pharmaceuticals, IncSold$58.1K

Companies traded

  • KLRA Kailera Therapeutics, Inc: other filings, last Sep 7, 2026
  • APLS Apellis Pharmaceuticals, Inc: 14 sales, last May 14, 2026

Get free alerts when Nur Nicholson files a new trade →